|
|
|
Journal of Bacteriology, July 2004, p . 4402-4406, Vol . 186, No . 13 Point Mutations in Transmembrane Helices 2 and 3 of ExbB and TolQ Affect Their Activities in Escherichia coli K-12Volkmar Braun* and Christina Herrmann Mikrobiologie/Membranphysiologie, Universität Tübingen, D-72076 Tübingen, Germany Received 6 February 2004/ Accepted 1 April 2004
ExbB and TolQ share the same transmembrane topology (15,
16, 27) . Starting with the N
terminus in the periplasm, they traverse the cytoplasmic membrane
three times (transmembrane segments in ExbB between residues 16 and
39, 128 and 155, and 162 and 199; total length, 244 residues) . ExbD
and TolR are anchored by the N-proximal region to the cytoplasmic
membrane (residues 23 to 43 in ExbD) and extend into the periplasm
(total length of ExbD, 141 residues) (14,
21) . Analysis of point mutants has demonstrated
the importance of the predicted transmembrane segments for ExbB and
ExbD and for TolQ and TolR activities . Replacement of the only
charged amino acid in or close to the transmembrane region of ExbD,
aspartate 25, with asparagine (D25N) abolishes ExbD activity (7),
and mutations at the equivalent position in TolR, D23A and D23R,
inactivate TolR (10) . In TolQ, mutation A13G In this study, we replaced glutamate in the highly conserved
sequence of the third transmembrane segment of ExbB and TolQ . This is
the only charged and polar residue in a stretch of 22 hydrophobic
amino acids . E176 in ExbB and E173 in TolQ were replaced with D, Q,
and A by using PCR . For exbB mutagenesis, plasmid pHE20 (8)
was used, and for tolQ mutagenesis, plasmid pHE12 (8)
was used . The mutagenesis primers were designed so that an XmaI
restriction site was introduced close to the site to be mutagenized .
Wherever possible, two nucleotides in the codons were replaced to
minimize reversion . The mutated exbB or tolQ gene was
carried on the low-copy-number vector pWSK29 (28),
which also contained wild-type exbD or tolR, respectively .
Plasmid-carried exbB and exbD or tolQ and tolR
were transcribed by their own promoters . The above mutations and the
lack of additional mutations were verified by nucleotide sequencing .
The sensitivities of mutant and wild-type cells to the group A
colicins E1, E2, and K, the group B colicins D and M, albomycin, and
phage
The results obtained with the TolQ mutants closely matched those obtained with the ExbB mutants (Table 1) . The TolQ(E173A) mutation inactivated TolQ function . The TolQ(E173Q) and TolQ(E173D) mutations affected the activity towards the group B colicins more than the activity towards the group A colicins . Thus, the residual activities of TolQ in ExbB-dependent functions were useful in identifying the small functional effects of TolQ mutations . The sensitivities of E . coli GM1 matched those of E . coli HE2 transformed with wild-type tolQ and tolR, except for sensitivity to colicin K, which was 10-fold higher in the transformants . A higher level of expression of tolQ and tolR in the transformants probably increased colicin K sensitivity . The transport activities of E . coli HE2 containing plasmid-carried mutant exbB genes were compared with the transport activities of E . coli HE2 transformed with the wild-type exbB gene . Cells were incubated with [55Fe3+]ferrichrome, collected on filters, and washed, and the radioactivity on the filters was measured using a liquid scintillation counter . Transport of the ExbB(E176A) mutant was totally impaired, whereas transport of ExbB(E176D) and ExbB(E176Q) mutant cells was somewhat reduced (Table 2) . The transport rate of E . coli GM1 was 77% of the transport rate of the wild-type exbB transformant (Table 2); this difference may be caused by the two to three exbBD gene copies in the transformant .
To examine whether the inactivity of the ExbB(E176A) and TolQ(E173A) mutants was caused by lack of the proteins, E . coli BL21 omp8 (23) was labeled with [35S]methionine . The exbB and exbD genes were cloned downstream of the gene 10 promoter of phage T7 on plasmid pT7-6 and transcribed by the T7 RNA polymerase encoded on the chromosome of E . coli BL21 omp8 under lacI control . In the labeling experiment, cells were treated with 0.2 µg of rifamycin/ml to inactivate the E . coli RNA polymerase . Proteins of transformants containing plasmid-carried wild-type or mutant exbB and tolQ genes were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) . The autoradiographs of the gels revealed similar amounts of ExbB and ExbD (Fig . 1A) and of TolQ and TolR (Fig . 1B), with the exception of TolQ(E173A), where only trace amounts of a labeled protein were observed . Examination of the nucleotide sequences of tolQ and of the region upstream of tolQ in the clone used for SDS-PAGE revealed no mutation other than the one yielding the TolQ(E173A) replacement . Different mutation strategies also yielded only transformants that contained trace amounts of the TolQ(E173A) mutant protein . Cells expressing TolQ(E173A) formed after centrifugation of sediments, which were difficult to suspend homogenously, suggesting alterations in cell surface properties . It is not clear how much the phenotype of the TolQ(E173A) mutant was influenced by the small amounts of the protein . To minimize additional mutations that down-regulate TolQ(E173A) synthesis or activity, the assays and the protein determinations were performed with freshly transformed cells . The TolQ(E173A) mutant synthesized only trace amounts of TolR also, as if the TolQ mutation destabilized not only TolQ but also the TolR protein that interacts with TolQ .
The phenotypes of the mutants indicate that E176 and E173 play important roles in the activities of ExbB and TolQ, respectively . However, E176 and E173 do not seem to be as essential in the c subunit of the ATPase of E . coli as D61, which is representative of a single aspartate residue in the hydrophobic c-subunit regions of H+-translocating ATPases . E176 is present in all 12 predicted ExbB proteins that we examined in the EMBL databank, and E173 is present in all 10 TolQ proteins examined . Recently, two proton conduction pathways have been proposed . In
one proposal, the pathway is formed by the three transmembrane
helices of ExbB and the transmembrane helix of ExbD; in the other,
the pathway is formed by the TonB transmembrane helix together with
the three ExbB transmembrane helices and the ExbD helix (29) .
In the former model, the protons move along residues as follows: T181
The rates of [55Fe3+]ferrichrome transport into cells carrying the amino acid replacements in the proposed ExbB proton conduction pathway were determined (Table 2) . Only the ExbB(T148A T181A) double mutant was virtually transport inactive . The other single and double mutants showed activities between 48 and 99% of that of the wild type . As was seen with the colicin assays, the TolQ(E173D) and TolQ(E173Q) mutations reduced ferrichrome transport more severely than the corresponding ExbB mutations . The selected residues are contained in the most conserved sequence, comprising 67 residues, of ExbB/TolQ; 57 of these are identical and 10 are conserved replacements in E . coli, Salmonella enterica serovar Typhimurium, Yersinia pestis, Pseudomonas putida, Rhizobium meliloti, and Brucella melitensis . They are part of transmembrane helices 2 and 3 and are connected by a small periplasmic loop in which amino acid variations are accumulated . When all sequences contained in the EMBL databank (46 sequences) were compared, T148 was found in all ExbB and TolQ homologs and T181 was found in all but two homologs (replaced by A or V) . S155 is less conserved (nine cases) and frequently is replaced by A in TolQ . The sensitivity of the mutants coincided with the conservation of the residues . The T148A and T181A mutants were resistant to the group A colicins and showed reduced sensitivity to the group B colicins . T148A T181A double mutants were completely resistant to all agents . It is possible that the predicted proton conductance is not completely interrupted by the single mutations but is completely interrupted by the double mutation . In the single mutants, water close to alanine might bridge the gap . The S155A mutation alone and in combination with T181A showed the slightest effects . Our data do not discriminate between the two proposed proton conduction pathways since the two mutations with the strongest effects, T148A and T181A, are contained in both pathways . However, since the S155A mutation showed only slight effects and the H20R (26), H20Y, and S16L mutations in TonB inactivate TonB (18), a proton conduction pathway that includes these two residues is more consistent with the data . The presence of similar sequences and transmembrane topologies in the flagellar motor proteins MotA and ExbB/TolQ and in MotB and ExbD/TolR has led to the proposal that there might also be functional similarities (10, 11, 17, 29) . MotA forms a channel through which protons flow (2) and interacts with the motor through FliG . Together with MotB, it forms the stator of the flagellar motor . MotA traverses the cytoplasmic membrane four times and could be comparable with ExbB if the single transmembrane region of TonB is added to the three transmembrane segments of ExbB (29) . MotB traverses the cytoplasmic membrane once with the same topology as ExbD and TolR . MotB contains an aspartate residue (D32) at the same position as in ExbD and TolR; D32 is strictly conserved among MotB proteins of various bacteria and replacement with asparagine abolishes motor function (3) . It has been proposed that flagellar rotation is driven by cyclic conformational changes in the stator which occur as protons bind to and dissociate from D32 of MotB (1) . D32 also plays a crucial role in the helix rotation model of the flagellar motor (25) . It is likely that the essential roles of D25 in ExbD, D23 in TolR, and D32 in MotB reflect similar functions . Proton-driven conformational changes have also been discussed as being involved in energy-coupled outer membrane transport processes mediated by TonB and TolA (4, 10, 11, 22) . If a proton conductance pathway through TonB/ExbB/ExbD and TolA/TolQ/TolR exists, E176 of ExbB and E173 of TolQ are likely to be involved . Reconstitution of these protein complexes in lipid vesicles will be required to demonstrate proton conductance and to determine the roles, which have been identified in this and other studies, that the amino acids play . MotA and MotB form large protein complexes with FliG, FliN, and FliM . It is likely that TonB, ExbB, and ExbD also form a complex . The molar ratio of the latter three proteins in cells amounts to 1:7:2 (13) . If this reflects the stoichiometry of the complex, it differs from that of MotA and MotB, for which a 4:2 ratio has been proposed (1) . A C-terminal fragment of TonB forms a dimer in the crystal (11) and in cells (24), and the formation of a dimer of two complete TonB molecules has been determined in vivo (24) . The stoichiometry could then be 2:14:4, which results in a protein complex of 520 kDa . This study was undertaken with two purposes in mind: (i) to determine whether the only charged and highly conserved E176 residue of ExbB and E173 of TolQ in the predicted transmembrane helix 3 plays an essential role in ExbB and TolQ activity and (ii) to determine whether experimental data can be obtained that support one or the other of the two proposed proton conductance pathways . This paper demonstrates that E176 of ExbB and probably E173 of TolQ are not essential for ExbB and TolQ activity and that the predicted proton pathways seem to function only when water bridges between nonpolar amino acid side chains are assumed . The data do not support one or the other of the two predicted proton pathways, if they exist at all .
This work was supported by the Fonds der Chemischen Industrie .
What is Food Microbiology?,
What Is Amino Acid?,
What Is Botulism?,
What Is Pcr?,
What Is Water Purification?,
s,
Microbiology,
i,
Microorganisms,
o,
Microbe,
s,
Bacterium,
n,
Microbes,
a,
Cholera,
c,
Enterococci,
e,
Thermophile,
n,
Escherichia coli,
s,
Acinetobacter,
a,
Campylobacter,
i,
Escherichia coli,
e,
Antibiotics,
c,
Bacteroides,
i,
Meningococcus,
n,
Escherichia coli,
a,
Antimicrobial,
a,
Staphylococcus aureus,
o,
Escherichia coli,
n,
Salmonella typhimurium,
n,
Pseudomonas aeruginosa,
o,
Microorganism,
c,
S. cerevisiae,
s,
Salmonella typhimurium,
r,
Salmonella typhimurium,
c,
Staphylococcus
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||